Specified (Dread) Disease Coverage

Specified (Dread) Disease Coverage is a type of insurance policy that provides benefits for the treatment of specific illnesses or diseases. Here are some key features of specified disease coverage:

  • Limited coverage: Specified disease coverage is usually limited to a specific list of illnesses or diseases, such as cancer, heart disease, or stroke.

  • Fixed benefits: The policy pays out a fixed amount of benefits for each covered condition, regardless of the actual costs of treatment.

  • No deductibles: Specified disease coverage usually does not have a deductible, meaning that benefits are paid out as soon as a covered condition is diagnosed.

  • Affordable premiums: Premiums for specified disease coverage are typically lower than for comprehensive health insurance, making it a more affordable option for those who may not be able to afford traditional health insurance.

  • Supplemental coverage: Specified disease coverage is often used as a supplement to comprehensive health insurance, providing additional financial protection for specific conditions.

Example: Let's say a person has a family history of cancer and is concerned about the potential cost of treatment if they were to be diagnosed with the disease. They purchase a specified disease coverage policy that provides a fixed benefit of $50,000 for cancer treatment. If the person is diagnosed with cancer, they would receive a payout of $50,000, which they could use to cover medical expenses, lost income, or other costs associated with the illness. The policy may also cover other specified diseases or illnesses, depending on the terms of the policy.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.